Prof. Dr. Simten Dağdaş
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 publicationsSource: OpenAlex / PubMed MeSHView publications
- Graft vs Host Disease 4 publications
- Leukemia, Lymphocytic, Chronic, B-Cell 4 publications
- Leukemia, Myeloid, Acute 3 publications
- Multiple Myeloma 3 publications
- Nervous System Diseases 2 publications
- Leukemia, Myeloid, Chronic-Phase 2 publications
- Thrombosis 2 publications
- Hodgkin Disease 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyHaematologysaglik.gov.trFrom source
- InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
- Area of workLeukemia, Myelogenous, Chronic, BCR-ABL PositiveExtracted from 5 publications · Model version —From source
- Publications134 publicationsORCID, OpenAlex, Europe PMCFrom source
- ORCID0000-0003-0901-2043ORCIDFrom source
- Last synchronised7 November 2026 00:02https://ankarasehir.saglik.gov.tr/TR-331019/hematoloji-klinigi-doktorlarimiz.html#simten-dagdassaglik.gov.tr
Scientific work
Publications on Leukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Salvage Autologous Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma: Long-Term Efficacy and Safety Outcomes from a Single-Center Real-World Cohort
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15187184 PMID 42795957 Open-access full textSource: ORCID
-
Clinical Spectrum and Differential Diagnosis of Adult Thrombotic Microangiopathies: Real-World Experience from a Tertiary Referral Center
Hematology Reports, 2026
DOI 10.3390/hematolrep18040049 PMID 42496448 Open-access full textSource: ORCID
-
Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center
Mediterranean Journal of Hematology and Infectious Diseases, 2026
DOI 10.4084/mjhid.2026.044 PMID 42136896 Open-access full textSource: ORCID
-
Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms
International Journal of Endocrinology, 2026
DOI 10.1155/ije/6041016 PMID 42147090 1 citation (Europe PMC) Open-access full textSource: ORCID
-
Prognostic Differences Between P190 and P210 BCR::ABL1 in Patients with Philadelphia-Positive B-cell Acute Lymphoblastic Leukemia
Indian Journal of Hematology and Blood Transfusion, 2026
DOI 10.1007/s12288-025-02095-8 PMID 41522562 Open-access full textSource: ORCID
-
Bidirectional Temporal Association Between Cytomegalovirus Reactivation and Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Real-World Cohort Study
Viruses, 2026
DOI 10.3390/v18080874 PMID 42655692 Open-access full textSource: ORCID
-
Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G-CSF Treatment in Unrelated Donors
Journal of Clinical Apheresis, 2026
DOI 10.1002/jca.70089 PMID 41500932 Open-access full textSource: ORCID
-
Steroid-associated hypofibrinogenemia: an overlooked risk in graft-versus-host disease management after allogeneic hematopoietic stem cell transplantation
Blood Coagulation & Fibrinolysis, 2026
DOI 10.1097/mbc.0000000000001460 PMID 42937018 Source: OpenAlex
-
Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group
Journal of Clinical Medicine, 2025
DOI 10.3390/jcm14196813 PMID 41095893 Open-access full textSource: OpenAlex
-
Ocular surface and corneal subbasal nerve plexus changes in ocular graft versus host disease patients treated with topical cyclosporine
BMC ophthalmology, 2025
DOI 10.1186/s12886-025-04366-4 PMID 41102752 1 citation (Europe PMC) Open-access full textSource: Europe PMC